학술논문

Co-supplementation of isomalto-oligosaccharides potentiates metabolic health benefits of polyphenol-rich cranberry extract in high fat diet-fed mice via enhanced gut butyrate production.
Document Type
Article
Source
European Journal of Nutrition. Dec2018, Vol. 57 Issue 8, p2897-2911. 15p. 1 Diagram, 5 Graphs.
Subject
*ANIMAL experimentation
*BUTYRIC acid
*CHEMOKINES
*COLON (Anatomy)
*CRANBERRIES
*DIETARY supplements
*FATTY acids
*FAT content of food
*GENE expression
*GLYCOPROTEINS
*INFLAMMATION
*OLIGOSACCHARIDES
*METABOLISM
*MICE
*OBESITY
*PLANT extracts
*GUT microbiome
*GLUCOSE intolerance
*LIPOPOLYSACCHARIDES
Language
ISSN
1436-6207
Abstract
Purpose: Cranberries are a rich source of polyphenolic antioxidants. Purified sugars or artificial sweeteners are being added to cranberry-based food products to mask tartness. Refined sugar and artificial sweeteners intake modulate gut microbiota and result in metabolic complications. We evaluated effects of isomalto-oligosaccharides (IMOs; sweet tasting non-digestible oligosaccharides) with cranberry extract (CRX) on high fat diet (HFD)-induced metabolic alterations in mice.Methods: Male Swiss albino mice were fed normal chow or HFD (58% fat kcal), and were administered either CRX (200 mg/kg) alone or in combination with IMOs (1 g/kg). Cecal short-chain fatty acids, abundances of selected (1) butyrate producing, (2) metabolically beneficial, and (3) selective lipopolysaccharides producing gram negative gut bacteria were studied. Further, gut-related histological, biochemical, genomic changes along with circulating pro-/anti-inflammatory markers and systemic obesity-associated metabolic changes were studied.Results: Co-supplementation of CRX and IMOs significantly improved cecal SCFAs, especially butyrate levels, selected butyrate-producing bacteria (clostridial cluster XIVa bacteria) and butyrate kinase expression in HFD-fed mice. The combination also significantly improved gut beneficial bacterial abundance, gut histology and related changes (colon mucin production, gut permeability) as compared to individual agents. It also prevented HFD-induced systemic and tissue inflammation, glucose intolerance and systemic obesity-associated metabolic changes in adipose tissue and liver. The combination of CRX and IMOs appeared more effective in the prevention of HFD-induced gut derangements.Conclusion: Combination of CRX and IMOs could be advantageous for normalization of metabolic alterations seen in diet-induced obesity via beneficial modulation of gastrointestinal health. [ABSTRACT FROM AUTHOR]